Founded in 1985, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (Shuyang) is now a subsidiary of China Grand Enterprises, Inc., with total assets exceeding 1.5 billion yuan and 1.5 billion yuan in annual sales revenue in 2018. The company operates 17 subsidiary plasmapheresis centers, selling products nationwide and in international markets for 15 years, and is a leading exporter of blood products in China; Shuyang was among the first blood products manufacturers in China to pass both GMP and ISO 9001 quality certification, and the first to simultaneously pass verification of quality (ISO 9001), environmental (ISO 14001) and occupational health (OHSAS 18001) systems in China. The company has received GMP approval through international inspections from Russia and Turkey, among others, with many products registered in Europe, Asia and South American countries.
No comments available.
Leave your rating & comment